Generic Portal

— Research Explorer

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/S0140-6736(22)02607-1
Final published version

Eric F. Morand
Edward M. Vital
Michelle Petri
Ronald van Vollenhoven
Daniel J. Wallace
Marta Mosca
Richard A. Furie
Maria E. Silk
Christina L. Dickson
Gabriella Meszaros
Bochao Jia
Brenda Crowe
Inmaculada de la Torre
Thomas Dörner

Original language	English
Pages (from-to)	1001-1010
Number of pages	10
Journal	The Lancet
Volume	401
Issue number	10381
Early online date	2023
DOIs	https://doi.org/10.1016/S0140-6736(22)02607-1
Publication status	Published - 25 Mar 2023

ID: 34926904